Japanese Stem Cells in Isei: Triple Crown in 2020-Bold Tact Stem Cell Transplantation

Daring Tact (mare 5: Sugiyama Chun, father: Epifaneia) is the triple crown in 2020. After winning the third place of Queen Elizabeth II Cup in Hong Kong on April 25th last year, she rested due to inflammation of the right front leg ligament. On June 16, this month, she moved from Omotomachi, Normandy Farm in Fukushima Prefecture to Champion Mountain in Shiga Prefecture. 18, Normandy thoroughbred horse company announced the news. Because he returned to the competition, he received a stem cell transplant, and then he received rehabilitation and training.

It is now ready to return to the Rito training center.

The treatment of stem cells is not limited to human treatment, but also applied to animals (pets).

Stem cells are not only used in human medicine, but also in other animal species. For example, the stem cell therapy of equine flexor tendinitis carried out by JRA Horse Racing Institute (JRA Institute) aims to eradicate the common flexor tendinitis in horse racing.

Flexor tendinitis is a disease that occurs in the legs of horses. It takes several months to several years to cure, and the affected part will not return to a healthy state. With the goal of radical cure, JRA comprehensive research institute is exploring the method of implanting bone marrow mesenchymal stem cells into the affected area and treating them through cytokines secreted by stem cells.

In addition to horse racing, beef cattle, cows and other economic animals, that is to say, stem cell therapy is also expanding. In the field of veterinary medicine, stem cell therapy is divided into tissue patch therapy, immune enhancement therapy and cytokine therapy.

By 20 17, clinical trials and product development of enterprises are being promoted in the treatment of spinal cord injury and liver diseases with cytokine therapy for livestock. Included in this cytokine therapy, and the treatment of various medical and surgical diseases is now in the stage of diagnosis and treatment in the hospital.

The following diseases have actually been clinically studied or reached the practical stage in the veterinary field.

Spinal cord diseases: central nervous system infarction such as disc herniation, spinal deformity, degenerative myelopathy, spinal cord restraint and cerebellar infarction.

Autoimmune diseases: keratoconjunctivitis sicca, atopic dermatitis, immune-mediated arthritis and aplastic anemia.

Diseases of internal medicine system: insulin-dependent diabetes, chronic pancreatitis, chronic hepatitis, liver failure, cirrhosis, nephritis, chronic kidney disease.

Others: fracture with incompleteness and skin trauma.

In the field of veterinary medicine, stem cells are used to treat or clinically study these diseases.

Japanese stem cells

Japan's high medical level has been recognized by the whole world. 20 12 and 20 16, two Japanese physicians, shinya yamanaka and yoshinori ohsumi, won the Nobel Prize in medicine in the field of regeneration. On the one hand, people expect the excellent curative effect of stem cells on diseases condemned as "powerless", on the other hand, people are worried about the safety of this new medical technology.

In order to ensure the safety of stem cell therapy, the Regenerative Medical Safety Law was passed in 20 14, which formally put stem cells under supervision and allowed medical institutions to use them as a medical technology in clinic. It was also after the passage of the bill that regenerative medicine in Japan began to spread among the people. 20 15 medical institutions began to apply for licenses for stem cell treatment in various parts of the human body. Facial injection must have a facial injection license, and treatment of corresponding diseases must also have a corresponding license. All medical institutions must report this year's treatment cases to the Ministry of Health, Labor and Welfare as a clinical basis. It can be said that this medical system in Japan has promoted the progress of regenerative medicine.

Japanese local hospital is the only designated trusteeship in China.

About us

Japan Stem Cell General Hospital sponsored by ISEI Health is the general hospital with the largest number of regenerative medicine cases and clinical cases in Japan, which provides a large number of case basis for Japan Regenerative Medicine Committee to formulate cell culture and treatment standards.

We are an overseas client (China) service custodian authorized by Japanese hospitals. Through the professional medical consultant team and translation team, we are committed to providing top-notch Japanese medical technology and safe and comfortable medical services to our customers in China.

In the past five years, in addition to local Japanese patients, we have also received political and business celebrities from South Korea, Singapore, the United States, Turkey and China.

We have passed the qualification examination of the Japanese government (Ministry of Economy, Trade and Industry and Ministry of Foreign Affairs). After strict examination, we are a professional company that legally conducts overseas guest business in Japan as the designated institution for ensuring the identity of Japanese medical visas and the qualification institution of Japanese travel industry. Again, we are not a third party, let alone an intermediary. We don't charge any other fees except the normal hospitalization fees and related service fees.

Pay attention to our private messages and get more regeneration information.